After auranofin treatment at the concentrations of 1, 5, or 10 mg/kg mouse survival was observed at 50, 30, and 20%, respectively within a 96-h period
J Diabetes Investig, 2021
Members typically pay upfront for three months or one month, with slightly lower per-month rates for longer commitments
To view a copy of this license, visit About this article Cite this article Zhou, D., Chen, YW., Zhao, ZH
Gastrointestinal adverse events Very common (10% or more): Diarrhea (35%), abdominal pain (21%), vomiting (21%), nausea (12%) Common (1% to 10%): Constipation, dyspepsia, gastrointestinal disorder, melena Very rare (less than 0.01%): Abdominal cramps [Ref] Nervous system Very common (10% or more): Headache (37%), dizziness (18%), paresthesia (12%) Common (1% to 10%): Hypertonia, vertigo, taste perversion Frequency not reported : Seizures (with or without pre-existing seizure activity), increase in seizure frequency and/or severity [Ref] Metabolic Very common (10% or more): Hypercalcemia (15%), hypervolemia (12%) Common (1% to 10%): Anorexia, hyperkalemia [Ref] There are reports from clinical trials of significant hypertriglyceridemia associated with high doses of levocarnitine (3 g/day) given to uremic dialysis patients
The key is to ensure that a portion of that fluid includes electrolytes so that the water actually hydrates your cells instead of just passing through your kidneys
